Navigation Links
Watson Confirms Viagra® Patent Challenge
Date:6/2/2011

PARSIPPANY, N.J., June 2, 2011 /PRNewswire/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Sildenafil Citrate Tablets, 25, 50 and 100 mg. Watson's Sildenafil Citrate tablets are a generic version of Pfizer Inc.'s Viagra®, which is indicated for the treatment of erectile dysfunction (ED).

Pfizer filed suit against Watson on June 1, 2011 in the United States District Court for the Southern District of New York seeking to prevent Watson from commercializing its product prior to the expiration of U.S. Patent No. 6,469,012.  Pfizer's lawsuit was filed under the provisions of the Hatch-Waxman Act, resulting in a stay of final FDA approval of Watson's ANDA until November 6, 2013 or until final resolution of the matter before the court, whichever occurs sooner, subject to any other exclusivities.  

For the twelve months ending April 30, 2011, Viagra® had total U.S. sales of just over $1 billion, according to IMS Health data.

About Watson Pharmaceuticals, Inc.Watson Pharmaceuticals, Inc. is an integrated global specialty pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health. Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.

Forward-Looking Statement Statements contained in this press release that refer to non-historical facts are forward-looking statements that reflect Watson's current perspectiv
'/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Launches Generic Biaxin(R) XL
2. Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
3. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
4. Watson Announces Positive Data for Its New Investigational Products for Benign Prostatic Hyperplasia and Overactive Bladder
5. Watson Announces United States Availability of RAPAFLO(TM) (silodosin), a Novel New Treatment in Benign Prostatic Hyperplasia (BPH)
6. Watson and Barr Settle Lawsuit Over Oxytrol(R)
7. Watson to Host Conference Call and Webcast to Discuss Fourth Quarter 2009 Earnings and 2010 Outlook
8. Watson Completes Acquisition of Eden Biodesign
9. Watson to Present at Credit Suisse Healthcare Conference
10. Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy
11. Watson Files FDA Application for Generic Rozerem(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... The Physician-Patient Alliance for Health & Safety (PPAHS) has ... Hospital Stay ." "Help us ensure patients ... patients went home from hospital," said Michael Wong ... the patient stories presented at the recent ... Monitoring of Patients on Opioids (shown above). "Yet, ...
(Date:7/28/2015)... July 28, 2015 At the ... Experience Association recognized 15 winners in the categories ... applied across multiple vertical markets. ContextMedia:Health proudly ... Award for its success with its first-to-market ... ContextMedia:Health, the leading provider of digital ...
(Date:7/28/2015)...  For many medical institutions and universities, commercializing patented ... can be a constant challenge. Taking an idea all ... rare. A new company in ... Medical Device Investments (MDI) was created to commercialize medical ... MDI develops, manufactures and markets the products, with the ...
Breaking Medicine Technology:Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2ContextMedia:Health Receives Top Award at the ICX Association Excellence Awards 2Medical Device Investments To Become Center Of Excellence For The Commercialization Of Innovative Medical Technologies 2
... voted the most powerful person in healthcare by readers of ... news magazine. It,s the second consecutive year Obama topped the ... Healthcare. "The passage of national healthcare reform legislation ... Modern Healthcare Editor David Burda. "The Patient Protection and ...
... Aug. 20 Cumberland Pharmaceuticals Inc.(Nasdaq: CPIX ... has extended its review of the supplemental new drug application ... in patients with non-acetaminophen acute liver failure. The review has ... Drug User Fee Act (PDUFA) goal date in December 2010. ...
Cached Medicine Technology:Obama Named the Most Powerful Person in Healthcare for Second Consecutive Year 2Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 2Cumberland Pharmaceuticals Announces Extension of FDA Review of Acetadote® Supplemental New Drug Application 3
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... new Total Heart Center at Memorial Regional Hospital, providing expert, streamlined total advanced ... will be suited to provide extensive heart services under one roof, including the ...
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... ... user-friendly navigation, portal to access industry practices, consumer education, resource library, floor plans, ... visitors from around the globe and offers regular posts with valuable links to ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... the Lost and Found, a breakthrough technological invention. It is a wearable ... the consumer electronic industry reached a record high of $211.3 billion in 2014," ...
(Date:7/28/2015)... ... , ... Morristown Medical Center, part of Atlantic Health System, today announced it ... in the nation, to implant the newly approved CoreValve® Evolut® R System from Medtronic. ... good condition. , The CoreValve® Evolut® R System was approved by the U.S. Food ...
(Date:7/28/2015)... ... July 28, 2015 , ... DuPont leaders today ... Ethiopia to learn more about the impact of U.S. collaborations with local partners ... on accelerating agricultural development as an engine of broad-based economic growth in the ...
Breaking Medicine News(10 mins):Health News:Memorial Cardiac And Vascular Institute Centralizes Cardiac Care Through It's New "Total Heart Center" At Memorial Regional Hospital 2Health News:Triumph Modular Launches Refreshed Modular Building Industry Website 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 2Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 3Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 4Health News:Getting Back to Basic with Bluetooth Is What the World Patent Marketing Review Team and Lost and Found Are All About 5Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 2Health News:Morristown Medical Center First Hospital in New Jersey to Implant Newly Approved Heart Valve 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 2Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 3Health News:US President learns from DuPont Innovations in Food and Agriculture in Ethiopia 4
... Optical technology is as accurate as colorectal tissue examination, ... Optical technology could help physicians detect small colorectal polyps ... , In the report, published online Nov. 10 in ... that the technique could replace histopathology, which requires more ...
... NEW YORK Medications frequently given to cancer patients ... an increased risk of deep vein thrombosis or pulmonary ... M.D, M.S., co-director of the breast cancer program at ... University Medical Center. The findings will be published online ...
... Care Hero Award Winners Saluted at Kickoff Event , ... today celebrated Health Careers Week in Pennsylvania by urging ... 10 in-demand allied health occupations. , "There will ... the state over the next seven years," said Governor ...
... Charis Eng, M.D., Ph.D., Chair and Director of Cleveland ... appointed to the U.S. Department of Health and Human ... (SACGHS) to serve a three-and-a-half year term. , ... medical, ethical, legal, and social implications of integrating genetic ...
... exactly sure how pathogens raise risk of brain attack , ... pathogens may increase the risk of having a stroke, a ... associate professor of neurology at Columbia University Medical Center in ... Chlamydia pneumoniae , Helicobacter pylori , cytomegalovirus and ...
... , JACKSONVILLE, Fla., Nov. 10 As Veterans Day approaches, ... mission is to honor and empower wounded warriors, is urging ... caregivers of the most severely injured veterans. , ... for has been merged into a larger Veterans Health Care ...
Cached Medicine News:Health News:New Polyp Detection Method Could Be Cost-Saver 2Health News:Drugs to treat anemia in cancer patients linked to thromboembolism 2Health News:Drugs to treat anemia in cancer patients linked to thromboembolism 3Health News:PA Governor Rendell Puts Focus of Health Careers Week on In-Demand Occupations 2Health News:PA Governor Rendell Puts Focus of Health Careers Week on In-Demand Occupations 3Health News:Cleveland Clinic Cancer Geneticist Charis Eng, M.D., Ph.D., Named To Federal Advisory Committee 2Health News:Common Infections May Contribute to Strokes 2Health News:Common Infections May Contribute to Strokes 3Health News:Wounded Warrior Project Urges the Senate to Support Crucial Family Caregiver Legislation 2
Endoscopes are also available in fully autoclavable models in 1.8, 2.7, 4.0. 5.0 and 10.0 mm diameters. Manufactured with precise swiss lenses. Built-in temperature measuring device to exactly determ...
Kaye Skin Hook, Single Prong...
Large....
These products are supplied non-sterile and must be sterilized before use. For insertion through the smokevac and nezhat-dorsey trumpet valve in conjunction with the universal instrument insert adapt...
Medicine Products: